2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope

Июль 28, 2022

Главная
Медицина
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope

Содержание

2. Citation This slide set is adapted from the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management
3. 2017 Syncope Guideline Writing Committee †ACC/AHA Task Force on Clinical Practice Guidelines Liaison. ‡ACC/AHA Representative. HRS
4. Table 1. Applying Class of Recommendation and Level of Evidence to Clinical Strategies, Interventions, Treatments, or
5. General Principles 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope
6. General Principles Syncope Initial Evaluation *See relevant terms and definitions in Table 3. Colors correspond to
7. History and Physical Examination Electrocardiography
8. Risk Assessment
9. Disposition After Initial Evaluation
10. Patient Disposition After Initial Evaluation for Syncope Colors correspond to Class of Recommendation in Table 1.
11. Additional Evaluation and Diagnosis 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope
12. Additional Evaluation and Diagnosis Colors correspond to Class of Recommendation in Table 1. *Applies to patients
13. Blood Testing
14. Cardiac Imaging Cardiovascular Testing
15. Stress Testing
16. Cardiac Monitoring
17. In-Hospital Telemetry
18. Electrophysiological Study
19. Tilt-Table Testing
20. Autonomic Evaluation Neurological Testing
21. Neurological and Imaging Diagnostics
22. Management of Cardiovascular Conditions 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope
23. Arrhythmic Conditions
24. Structural Conditions
25. Arrhythmogenic Right Ventricular Cardiomyopathy
26. Cardiac Sarcoidosis
27. Brugada Syndrome Inheritable Arrhythmic Conditions
28. Short-QT Syndrome
29. Long-QT Syndrome
30. Catecholaminergic Polymorphic Ventricular Tachycardia
31. Early Repolarization Pattern
32. Reflex Conditions 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope
33. Reflex Conditions Vasovagal Syncope
34. Vasovagal Syncope (cont.)
35. Vasovagal Syncope Colors correspond to Class of Recommendation in Table 1. VVS indicates vasovagal syncope.
36. Pacemakers in Vasovagal Syncope SR indicated systematic review.
37. Carotid Sinus Syndrome
38. Orthostatic Hypotension 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope
39. Orthostatic Hypotension Neurogenic Orthostatic Hypotension
40. Neurogenic Orthostatic Hypotension (cont.)
41. Dehydration and Drugs
42. Orthostatic Hypotension Colors correspond to Class of Recommendation in Table 1. BP indicates blood pressure; OH,
43. Pseudosyncope 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope
44. Treatment of Pseudosyncope
45. Age, Lifestyle, and Special Populations 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With
46. Pediatric Syncope Age, Lifestyle, and Special Populations
47. Pediatric Syncope (cont.)
48. Adult Congenital Heart Disease
49. Geriatric Patients
50. Driving and Syncope
52. Скачать презентацию

Слайд 2

Citation
This slide set is adapted from the 2017 ACC/AHA/HRS Guideline for

the Evaluation and Management of Patients With Syncope. Published on March 8, 2017, available at: Journal of the American College of Cardiology www.onlinejacc.org/lookup/doi/10.1016/j.jacc.2017.03.003) and Circulation (http://circ.ahajournals.org/lookup/doi/10.1161/CIR.0000000000000499).
The full-text guidelines are also available on the following Web sites: ACC (www.acc.orgThe full-text guidelines are also available on the following Web sites: ACC (www.acc.org), AHA (professional.heart.org), and the Heart Rhythm Society (www.hrsonline.org).

Слайд 3

2017 Syncope Guideline Writing Committee
†ACC/AHA Task Force on Clinical Practice Guidelines

Liaison. ‡ACC/AHA Representative. HRS Representative. ║ACEP and SAEM Joint Representative. ¶ACC/AHA Task Force on Performance Measures Liaison.

Win-Kuang Shen, MD, FACC, FAHA, FHRS, Chair†
Robert S. Sheldon, MD, PhD, FHRS, Vice Chair

Слайд 4

Table 1. Applying Class of Recommendation and Level of Evidence to

Clinical Strategies, Interventions, Treatments, or Diagnostic Testing
in Patient Care*
(Updated August 2015)

Слайд 5

General Principles
2017 ACC/AHA/HRS Guideline for the Evaluation and
Management of

Patients With Syncope

Слайд 6

General Principles
Syncope Initial Evaluation
*See relevant terms and definitions in Table

3.
Colors correspond to Class of Recommendation in Table 1. This figure shows the general principles for initial evaluation of all patients after an episode of syncope.
ECG indicates electrocardiogram.

Слайд 7

History and Physical Examination
Electrocardiography

Слайд 8

Risk Assessment

Слайд 9

Disposition After Initial Evaluation

Слайд 10

Patient Disposition After Initial Evaluation for Syncope
Colors correspond to Class of

Recommendation in Table 1.
ED indicates emergency department; pts, patients.

Слайд 11

Additional Evaluation and Diagnosis
2017 ACC/AHA/HRS Guideline for the Evaluation and

Management of Patients With Syncope

Слайд 12

Additional Evaluation and Diagnosis
Colors correspond to Class of Recommendation in

Table 1.
*Applies to patients after a normal initial evaluation without significant injury or cardiovascular morbidities; patients followed up by primary care physician as needed.
†In selected patients (see Section 1.4).
CT indicates computed tomography; CV, cardiovascular; ECG, electrocardiogram; EPS, electrophysiological study; MRI, magnetic resonance imaging; OH, orthostatic hypotension; and TTE, transthoracic echocardiography.

Слайд 13